Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

627
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
627
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

584
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
584
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

753
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
753
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

725
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
725
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.3K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.3K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

732
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
732

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The preparticipation physical examination: steps toward consensus and uniformity.

The Physician and sportsmedicine·2010
Same author

Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening.

British journal of sports medicine·2009
Same author

Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy.

Heart (British Cardiac Society)·2007
Same author

Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance.

Heart (British Cardiac Society)·2005
Same author

From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy.

Heart (British Cardiac Society)·2003
Same author

Extreme hypertrophic cardiomyopathy.

Heart (British Cardiac Society)·2003

Related Experiment Video

Updated: Mar 17, 2026

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

3.1K

Hypertrophic Cardiomyopathy in Athletes.

B J Maron

    The Physician and Sportsmedicine
    |July 19, 2016
    PubMed
    Summary

    Hypertrophic cardiomyopathy (HCM) is a significant cause of sudden cardiac death in young athletes. Management involves medication, surgery for obstruction, and avoiding strenuous exercise.

    Area of Science:

    • Cardiology
    • Sports Medicine
    • Genetics

    Background:

    • Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death in young athletes.
    • HCM presents a wide spectrum of clinical and morphological features.
    • Diastolic dysfunction is common, with 25% experiencing left ventricular outflow tract obstruction.

    Purpose of the Study:

    • To summarize the key aspects of hypertrophic cardiomyopathy (HCM).
    • To outline diagnostic and therapeutic strategies for HCM.
    • To provide guidance on exercise recommendations for individuals with HCM.

    Main Methods:

    • Review of existing literature on hypertrophic cardiomyopathy.
    • Echocardiography as a primary diagnostic tool.
    • Pharmacologic and surgical treatment considerations.

    More Related Videos

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
    03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    4.4K
    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
    06:02

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

    Published on: November 2, 2020

    6.3K

    Related Experiment Videos

    Last Updated: Mar 17, 2026

    Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice
    04:45

    Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

    Published on: May 5, 2022

    3.1K
    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
    03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    4.4K
    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
    06:02

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

    Published on: November 2, 2020

    6.3K

    Main Results:

    • HCM is a leading cause of sudden death in young athletes.
    • Echocardiography is crucial for diagnosis.
    • Medications like propranolol and verapamil can manage symptoms.

    Conclusions:

    • HCM requires careful management, including medication and potentially surgery.
    • Individuals with HCM should avoid competitive and strenuous physical activities.
    • Moderate recreational exercise may be permissible for some patients with HCM.